ITUS Corporation is an early cancer detection technology company currently developing a platform called Cchek, a series of inexpensive, non-invasive blood tests for the early detection of cancer. Specifically, the test will […]

CytRx Corporation is a clinical-stage, biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. CytRx’s initial focus is on seeking regulatory approval for and commercialization of it’s […]

Numerous global public and private initiatives are underway offering exceptional opportunity to revolutionize healthcare delivery. More advanced diagnostic techniques, based on individual patient characteristics including biomarker identification, evidence-based medicine, and a quality over […]

Creatv MicroTech is a company that understands that cancer will, at some point, likely touch us, our families and friends. In the U.S. alone, 43% of men and 38% of women will […]

CivaTech Oncology, Inc. (“CivaTech” or the “Company”) has developed a major technological advance in the radiation treatment of cancerous tumors. CivaTech products significantly reduce the side effects experienced from traditional implantable radiation […]

Valisure is a start-up company founded in 2015 in New Haven, CT by a group of Yale and Harvard alumni with proven biotech industry success (recent exit: Ion Torrent $725M). Valisure’s disruptive […]

CancerVacs is developing intralymphnode immunotherapeutics for certain metastatic cancer patients with no therapeutic options. This includes disseminated follicular lymphoma, glioblastoma multiforme, metastatic castrate-resistant prostate carcinoma, malignant melanoma, or other metastatic solid tumor. […]

Promaxo, a medical device startup focusing on portable MRI and other technology, is developing and commercializing an office-based, portable MRI with cellular level spatial resolution. Also in development is a real time […]